Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,599 | -43,543 | -28,909 | -13,362 | -7,180 |
| Depreciation Amortization | 854 | 859 | 829 | 701 | 746 |
| Other Working Capital | 508 | -642 | 5,090 | 392 | -1,669 |
| Other Operating Activity | 17,192 | 4,250 | 858 | 264 | 172 |
| Operating Cash Flow | $-29,045 | $-39,076 | $-22,132 | $-12,005 | $-7,931 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 576 | 298 | 247 | 5,206 | -5,000 |
| PPE Investments | -921 | -4,667 | -4,994 | -482 | -1,384 |
| Other Investing Activity | -2,865 | -4,932 | 0 | 0 | 13 |
| Investing Cash Flow | $-3,210 | $-9,301 | $-4,747 | $4,724 | $-6,371 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,368 | 35,059 | 63,707 | N/A | 32,452 |
| Financing Cash Flow | $2,368 | $35,059 | $63,707 | $N/A | $32,452 |
| Exchange Rate Effect | -67 | -829 | 127 | 8 | -232 |
| Beginning Cash Position | 39,246 | 53,393 | 16,438 | 23,649 | 5,731 |
| End Cash Position | 9,292 | 39,246 | 53,393 | 16,376 | 23,649 |
| Net Cash Flow | $-29,954 | $-14,147 | $36,955 | $-7,273 | $17,918 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,045 | -39,076 | -22,132 | -12,005 | -7,931 |
| Capital Expenditure | -921 | -4,667 | -5,001 | -482 | -1,384 |
| Free Cash Flow | -29,966 | -43,743 | -27,133 | -12,487 | -9,315 |